Глава МИД Польши призвал Европу исправить одну ошибку14:54
• 点评：超重/肥胖症是心血管病、糖尿病、MASH等多种慢病的核心病因。埃诺格鲁肽作为“同类首创”GLP-1新药，为患者提供了更舒适、更可持续的长期治疗选择。（罗仙仙）。关于这个话题，新收录的资料提供了深入分析
，详情可参考新收录的资料
India’s IT ministry and the Karnataka chief minister’s office did not respond to requests for comment on the proposal. Google, Snap, and X also did not respond to requests for comment.
cert that wasn’t EV when previously it had an EV cert，这一点在新收录的资料中也有详细论述